story of the week
Circulating Tumor Cell Prediction in Patients With HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial
Oncologist 2023 Nov 03;[EPub Ahead of Print], L Gerratana, M Kocherginsky, AA Davis, P D'Amico, C Reduzzi, F Puglisi, M CristofanilliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.